glp-1 nausea lawsuit in michigan How hospitalists can manage GLP-1s the hospital setting While many patients are seeing

Data on bone health in the context of calorie restriction and bariatric surgery were also summarized

Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2mmol/mol, 11.3, 11.6, p=0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9mmol/mol, 1.1, 20.6, p=0.032)

GLP-1 Patches

New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.

Meet Your New Daily Multi+

Alex Zhavoronkov, discussed how the GLP-1 revolution is expanding beyond weight loss toward healthy longevity